Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 2Breast Neoplasms 2Pain 1Lung Neoplasms 1Arthritis, Rheumatoid 1Agnosia 1

Interventions

Adalimumab 10Etanercept 9Methotrexate 4Infliximab 3tofacitinib 2Rituximab 2Leflunomide 2Abatacept 2tocilizumab 1sarilumab 1golimumab 1entecavir 1Tumor Necrosis Factor Inhibitors 1Sulfasalazine 1Prednisone 1Licensure 1Hydroxychloroquine 1Glucocorticoids 1Folic Acid 1Chloroquine 1Certolizumab Pegol 1Azathioprine 1Antirheumatic Agents 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Arthritis, Rheumatoid × Anti-Inflammatory Agents, Non-Steroidal × Clear all
NCT02878161 2016-08-25

Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

Central South University

Phase 4 Unknown
240 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡